Hofseth BioCare ASA hereby announces that it has raised MNOK 22.56 in proceeds through a private placement of 7,048,734 shares, each with a par value of NOK 1.00, at a subscription price of NOK 3.20 per share pursuant to an authorization from the general meeting to the board as of 22 March 2013. The New Shares have been subscribed by funds managed by Storebrand Kapitalforvaltning and DNB Asset Management. The Private Placement means the shareholders preferential rights pursuant to the Public Limited Liabilities Act § 10-4 has been derogated from.
The new shares will represent approximately 9.1% of the outstanding share capital of Hofseth BioCare ASA following the completion of the Private Placement and are expected to be listed on or about 2 July 2013.
After the issue of New Shares, Hofseth BioCare ASA will have 77,536,088 outstanding votes and shares.
"HBC has recently used significant resources to reach further into the value chain for our products and this gives us the opportunity to focus and follow up on the requests we've already have received from the market. Price indications for finished consumer products are attractive for HBC and we are going to pursue this further, "says CEO Jon Olav Ødegård in Hofseth BioCare ASA.
For further information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel +47 936 32 966
E-mail: joo@h-bc.no
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel +47 936 32 966
E-mail: joo@h-bc.no
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.